This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2004
Title: Symon G Erskine: Innovator in Cancer Treatment
Introduction
Symon G Erskine is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent.
Latest Patents
Symon G Erskine holds a patent for "Compounds and methods for the treatment of neoplastic disease." This patent describes a method of modulating the activity of an aberrant cell topoisomerase enzyme. The method involves contacting the enzyme with a compound that inhibits enzyme-mediated cleavage of a polynucleotide substrate with which the enzyme is in complex. The pharmaceutical compositions containing such compounds may be used to treat neoplasias or to inhibit the growth of certain cancer cells. Additionally, screening methods can be employed to identify other compounds for these uses. He has 1 patent to his name.
Career Highlights
Throughout his career, Symon G Erskine has focused on developing innovative solutions for complex medical challenges. His work has the potential to impact the treatment of cancer significantly.
Collaborations
Symon has collaborated with notable individuals in his field, including Michael N Gwynn and Neil David Pearson. Their combined expertise contributes to the advancement of cancer treatment methodologies.
Conclusion
Symon G Erskine's contributions to cancer treatment through his innovative patent highlight his role as a significant inventor in the medical field. His work continues to pave the way for future advancements in the treatment of neoplastic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile